vs
REPLIGEN CORP(RGEN)与Resolute Holdings Management, Inc.(RHLD)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Resolute Holdings Management, Inc.的1.7倍($197.9M vs $117.7M),REPLIGEN CORP净利率更高(6.7% vs -1.5%,领先8.2%),Resolute Holdings Management, Inc.自由现金流更多($189.2M vs $17.6M)
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业,核心业务布局于非洲地区,目前运营两座金矿,分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿,专注于黄金资源的勘探、开采及相关运营管理工作。
RGEN vs RHLD — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$117.7M
净利率更高
RGEN
高出8.2%
-1.5%
自由现金流更多
RHLD
多$171.7M
$17.6M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $197.9M | $117.7M |
| 净利润 | $13.3M | $-1.7M |
| 毛利率 | 52.5% | 55.7% |
| 营业利润率 | 9.0% | 30.2% |
| 净利率 | 6.7% | -1.5% |
| 营收同比 | 13.6% | — |
| 净利润同比 | 143.9% | — |
| 每股收益(稀释后) | $0.24 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RGEN
RHLD
| Q4 25 | $197.9M | $117.7M | ||
| Q3 25 | $188.8M | $120.9M | ||
| Q2 25 | $182.4M | $119.6M | ||
| Q1 25 | $169.2M | $103.9M | ||
| Q4 24 | $174.1M | — | ||
| Q3 24 | $154.9M | — | ||
| Q2 24 | $154.1M | — | ||
| Q1 24 | $151.3M | — |
净利润
RGEN
RHLD
| Q4 25 | $13.3M | $-1.7M | ||
| Q3 25 | $14.9M | $-231.0K | ||
| Q2 25 | $14.9M | $-611.0K | ||
| Q1 25 | $5.8M | $-3.4M | ||
| Q4 24 | $-30.3M | — | ||
| Q3 24 | $-654.0K | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $2.1M | — |
毛利率
RGEN
RHLD
| Q4 25 | 52.5% | 55.7% | ||
| Q3 25 | 53.2% | 59.0% | ||
| Q2 25 | 50.0% | 57.5% | ||
| Q1 25 | 53.6% | 52.5% | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 50.0% | — | ||
| Q2 24 | 49.8% | — | ||
| Q1 24 | 49.5% | — |
营业利润率
RGEN
RHLD
| Q4 25 | 9.0% | 30.2% | ||
| Q3 25 | 8.9% | 34.3% | ||
| Q2 25 | 7.6% | 34.0% | ||
| Q1 25 | 3.9% | 24.7% | ||
| Q4 24 | -17.7% | — | ||
| Q3 24 | -5.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 1.3% | — |
净利率
RGEN
RHLD
| Q4 25 | 6.7% | -1.5% | ||
| Q3 25 | 7.9% | -0.2% | ||
| Q2 25 | 8.2% | -0.5% | ||
| Q1 25 | 3.4% | -3.2% | ||
| Q4 24 | -17.4% | — | ||
| Q3 24 | -0.4% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 1.4% | — |
每股收益(稀释后)
RGEN
RHLD
| Q4 25 | $0.24 | $-0.20 | ||
| Q3 25 | $0.26 | $-0.03 | ||
| Q2 25 | $0.26 | $-0.07 | ||
| Q1 25 | $0.10 | $-0.39 | ||
| Q4 24 | $-0.55 | — | ||
| Q3 24 | $-0.01 | — | ||
| Q2 24 | $0.06 | — | ||
| Q1 24 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $767.6M | $205.5M |
| 总债务越低越好 | $542.2M | $169.8M |
| 股东权益账面价值 | $2.1B | $6.5M |
| 总资产 | $2.9B | $333.4M |
| 负债/权益比越低杠杆越低 | 0.26× | 26.03× |
8季度趋势,按日历期对齐
现金及短期投资
RGEN
RHLD
| Q4 25 | $767.6M | $205.5M | ||
| Q3 25 | $748.7M | $148.0M | ||
| Q2 25 | $708.9M | $99.9M | ||
| Q1 25 | $697.2M | $71.0M | ||
| Q4 24 | $757.4M | — | ||
| Q3 24 | $784.0M | — | ||
| Q2 24 | $809.1M | — | ||
| Q1 24 | $780.6M | — |
总债务
RGEN
RHLD
| Q4 25 | $542.2M | $169.8M | ||
| Q3 25 | $537.9M | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | $525.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
RGEN
RHLD
| Q4 25 | $2.1B | $6.5M | ||
| Q3 25 | $2.1B | $10.8M | ||
| Q2 25 | $2.1B | $9.6M | ||
| Q1 25 | $2.0B | $8.9M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.0B | — |
总资产
RGEN
RHLD
| Q4 25 | $2.9B | $333.4M | ||
| Q3 25 | $2.9B | $293.2M | ||
| Q2 25 | $2.9B | $253.3M | ||
| Q1 25 | $2.9B | $214.3M | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.9B | — | ||
| Q1 24 | $2.8B | — |
负债/权益比
RGEN
RHLD
| Q4 25 | 0.26× | 26.03× | ||
| Q3 25 | 0.26× | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $25.7M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $17.6M | $189.2M |
| 自由现金流率自由现金流/营收 | 8.9% | 160.8% |
| 资本支出强度资本支出/营收 | 4.1% | 5.8% |
| 现金转化率经营现金流/净利润 | 1.93× | — |
| 过去12个月自由现金流最近4个季度 | $93.9M | $313.2M |
8季度趋势,按日历期对齐
经营现金流
RGEN
RHLD
| Q4 25 | $25.7M | $196.1M | ||
| Q3 25 | $48.1M | $59.6M | ||
| Q2 25 | $28.6M | $48.9M | ||
| Q1 25 | $15.0M | $18.4M | ||
| Q4 24 | $39.2M | — | ||
| Q3 24 | $49.3M | — | ||
| Q2 24 | $42.2M | — | ||
| Q1 24 | $44.7M | — |
自由现金流
RGEN
RHLD
| Q4 25 | $17.6M | $189.2M | ||
| Q3 25 | $43.4M | $58.6M | ||
| Q2 25 | $21.5M | $47.5M | ||
| Q1 25 | $11.4M | $17.8M | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $42.3M | — | ||
| Q2 24 | $37.4M | — | ||
| Q1 24 | $36.4M | — |
自由现金流率
RGEN
RHLD
| Q4 25 | 8.9% | 160.8% | ||
| Q3 25 | 23.0% | 48.5% | ||
| Q2 25 | 11.8% | 39.7% | ||
| Q1 25 | 6.8% | 17.1% | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 27.3% | — | ||
| Q2 24 | 24.3% | — | ||
| Q1 24 | 24.0% | — |
资本支出强度
RGEN
RHLD
| Q4 25 | 4.1% | 5.8% | ||
| Q3 25 | 2.5% | 0.8% | ||
| Q2 25 | 3.9% | 1.2% | ||
| Q1 25 | 2.1% | 0.6% | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 5.5% | — |
现金转化率
RGEN
RHLD
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.23× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.57× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.70× | — | ||
| Q1 24 | 21.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图